Effects of resveratrol and genistein on nuclear factor-κB, tumor necrosis factor-α and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease

Molecular Medicine Reports

Volumn 13, Issue 5, 2016, Pages 4266-4272

  Liu, Xiao Ju ^a   Bao, Hai Rong ^a   Zeng, Xiao Li ^a   Wei, Jun Ming ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Chronic obstructive; Genistein; Matrix metalloproteinase 9; Nuclear factor B; Pulmonary disease; Resveratrol; Tumor necrosis factor

Indexed keywords

BRONCHODILATING AGENT; DEXAMETHASONE; GELATINASE B; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; SHORT ACTING DRUG; TUMOR NECROSIS FACTOR ALPHA; MMP9 PROTEIN, HUMAN; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFICACY; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTE; MALE; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; SUPERNATANT; METABOLISM; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GENISTEIN; HUMANS; LYMPHOCYTES; MALE; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84964754195     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.5057     Document Type: Article

References (33)

1. Barnes PJ: Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 35:71-86, 2014.
2. Eurlings IM, Dentener MA, Mercken EM, De Cabo R, Bracke KR, Vernooy JH, Wouters EF and Reynaert NL: A comparative study of matrix remodeling in chronic models for COPD; mechanistic insights into the role of TNF-α. Am J Physiol Lung Cell Mol Physiol 307:L557-L565, 2014.
3. Mohan D, Gale NS, McEniery CM, Bolton CE, Cockcroft JR, MacNee W, Fuld J, Lomas DA, Calverley PM, Shale DJ, et al; ERICA Consortium: Evaluating the role of inflammation in chronic airways disease: The ERICA study. COPD 11:552-559, 2014.
4. Kersul AL, Iglesias A, Ríos Á, Noguera A, Forteza A, Serra E, Agustí A and Cosío BG: Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 47:176-183, 2011.
5. Barnes PJ and Karin M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997.
6. Jayasooriya RG, Dilshara MG, Park SR, Choi YH, Hyun JW, Chang WY, and Kim GY: 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-kB pathway. Toxicol In Vitro 28:751-758, 2014.
7. Tung BT, Rodríguez-Bies E, Talero E, Gamero-Estévez E, Motilva V, Navas P and López-Lluch G: Anti-inflammatory effect of resveratrol in old mice liver. Exp Gerontol 64:1-7, 2015.
8. Park EJ and Pezzuto JM: The pharmacology of resveratrol in animals and humans. Biochim Biophys Acta 1852:1071-1113, 2015.
9. Chen L, Yang S, Zumbrun EE, Guan H, Nagarkatti PS and Nagarkatti M: Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages. Mol Nutr Food Res 59:853-864, 2015.
10. Chen J, Zhou H, Wang J, Zhang B, Liu F, Huang J, Li J, Lin J, Bai J and Liu R: Therapeutic effects of resveratrol in a mouse model of HDM-induced allergic asthma. Int Immunopharmacol 25:43-48, 2015.
11. Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM and Hong Y: Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-kB-dependent inflammatory/MMP-9 pathway. CNS Neurosci Ther 20:182-185, 2014.
12. Gupta SC, Tyagi AK, Deshmukh-Taskar P, Hinojosa M, Prasad S and Aggarwal BB: Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys 559:91-99, 2014.
13. Gao F, Wei D, Bian T, Xie P, Zou J, Mu H, Li J, Lin J, Bai J and Liu R: Genistein attenuated allergic airway inflammation by modulating the transcription factors T-bet, GATA-3 and STAT-6 in a murine model of asthma. Pharmacology 89:229-236, 2012.
14. Zhang Y, Dong J, He P, Li W, Zhang Q, Li N and Sun T: Genistein inhibit cytokines or growth factor-induced proliferation and transformation phenotype in fibroblast-like synoviocytes of rheumatoid arthritis. Inflammation 35:377-387, 2012.
15. Liu XJ, Zhao J and Gu XY: The effects of genistein and puerarin on the activation of nuclear factor-kappaB and the production of tumor necrosis factor-αlpha in asthma patients. Pharmazie 65:127-131, 2010.
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. www.goldcopd.org. Accessed December 31, 2011.
17. Martin-Piedra MA, Garzon I, Oliveira AC, Alfonso-Rodriguez CA, Carriel V, Scionti G and Alaminos M: Cell viability and proliferation capability of long-term human dental pulp stem cell cultures. Cytotherapy 16:266-277, 2014.
18. Singh R, Mackay AJ, Patel AR, Garcha DS, Kowlessar BS, Brill SE, Donnelly LE, Barnes PJ, Donaldson GC and Wedzicha JA: Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease. Respir Res 15:114, 2014.
19. Fischer BM, Voynow JA and Ghio AJ: COPD: Balancing oxidants and antioxidants. Int J Chron Obstruct Pulmon Dis 10:261-276, 2015.
20. Hirota N and Martin JG: Mechanisms of airway remodeling. Chest 144:1026-1032, 2013.
21. Yao H, Hwang JW, Sundar IK, Friedman AE, McBurney MW, Guarente L, Gu W, Kinnula VL and Rahman I: SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. Am J Physiol Lung Cell Mol Physiol 305:L615-L624, 2013.
22. Gross NJ: Novel antiinflammatory therapies for COPD. Chest 142:1300-1307, 2012.
23. Knobloch J, Wahl C, Feldmann M, Jungck D, Strauch J, Stoelben E and Koch A: Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. Basic Clin Pharmacol Toxicol 114:202-209, 2014.
24. Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ and Belvisi MG: Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J 19:840-841, 2005.
25. Lee SJ and Kim M: Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells. Life Sci 88:465-472, 2011.
26. Yu H, Pan C, Zhao S, Wang Z, Zhang H and Wu W: Resveratrol inhibits tumor necrosis factor-αlpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 62:366-372, 2008.
27. Knobloch J, Hag H, Jungck D, Urban K and Koch A: Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease. Basic Clin Pharmacol Toxicol 109:138-143, 2011.
28. Bime C, Wei CY, Holbrook J, Smith LJ and Wise RA: Association of dietary soy genistein intake with lung function and asthma control: A post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J 21:398-404, 2012.
29. Kalhan R, Smith LJ, Nlend MC, Nair A, Hixon JL and Sporn PH: A mechanism of benefit of soy genistein in asthma: Inhibition of eosinophil p38-dependent leukotriene synthesis. Clin Exp Allergy 38:103-112, 2008.
30. Hirayama F, Lee AH, Binns CW, Hiramatsu N, Mori M and Nishimura K: Dietary intake of isoflavones and polyunsaturated fatty acids associated with lung function, breathlessness and the prevalence of chronic obstructive pulmonary disease: Possible protective effect of traditional Japanese diet. Mol Nutr Food Res 54:909-917, 2010.
31. Li J, Li J, Yue Y, Hu Y, Cheng W, Liu R, Pan X and Zhang P: Genistein suppresses tumor necrosis factor a-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor k B and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells. Drug Des Devel Ther 8:315-323, 2014.
32. Jeong JW, Lee HH, Han MH, Kim GY, Kim WJ and Choi YH: Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia. Chem Biol Interact 212:30-39, 2014.
33. Wu CY, Hsieh HL, Sun CC, Tseng CP and Yang CM: IL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes. J Neurochem 105:1499-1512, 2008.